These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 33009692)

  • 1. Prognostic value of immune-related genes and immune cell infiltration analysis in the tumor microenvironment of head and neck squamous cell carcinoma.
    Wang Z; Yuan H; Huang J; Hu D; Qin X; Sun C; Chen G; Wang B
    Head Neck; 2021 Jan; 43(1):182-197. PubMed ID: 33009692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC.
    Ding Y; Chu L; Cao Q; Lei H; Li X; Zhuang Q
    BMC Cancer; 2023 Jan; 23(1):45. PubMed ID: 36639648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
    Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
    Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
    [No Abstract]   [Full Text] [Related]  

  • 4.
    Chen L; Lin J; Lan B; Xiong J; Wen Y; Chen Y; Chen CB
    Comput Math Methods Med; 2022; 2022():5851755. PubMed ID: 36510584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CELSR3 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment.
    Wu Z; Zhu Z; Wu W; Hu S; Cao J; Huang X; Xie Q; Deng C
    Eur Arch Otorhinolaryngol; 2024 Jun; 281(6):3143-3156. PubMed ID: 38507078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma.
    Wang J; Tian Y; Zhu G; Li Z; Wu Z; Wei G; Zhuang L; Li Z; Chen X; Zhang X; Zheng J; Cai G
    Int Immunopharmacol; 2021 Aug; 97():107817. PubMed ID: 34091115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a metabolic reprogramming-related signature associated with prognosis and immune microenvironment of head and neck squamous cell carcinoma by in silico analysis.
    Qiang W; Dai Y; Xing X; Sun X
    Cancer Med; 2022 Aug; 11(16):3168-3181. PubMed ID: 35301800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Infiltration-Related ceRNA Network Revealing Potential Biomarkers for Prognosis of Head and Neck Squamous Cell Carcinoma.
    Zhao S; Peng M; Wang Z; Cao J; Zhang X; Yu R; Huang T; Lian W
    Dis Markers; 2022; 2022():1014347. PubMed ID: 36097539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of immune cell infiltration and significant genes in head and neck squamous cell carcinoma.
    Zhang S; Zhang W; Zhang J
    Oral Oncol; 2022 Mar; 126():105755. PubMed ID: 35144208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
    Zhang F; Liu Y; Yang Y; Yang K
    BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
    Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
    BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Wei Z; Shen Y; Zhou C; Cao Y; Deng H; Shen Z
    Bioengineered; 2022 May; 13(5):13784-13800. PubMed ID: 35712757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Signature of N
    Chen J; Lu T; Zhong F; Lv Q; Fang M; Tu Z; Ji Y; Li J; Gong X
    Front Immunol; 2022; 13():809872. PubMed ID: 35185897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening the key genes of prognostic value in the microenvironment for head and neck squamous cell carcinoma.
    Meng D; Liu T; Ma F; Wang M
    Medicine (Baltimore); 2021 Jan; 100(4):e24184. PubMed ID: 33530209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SLA2 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment.
    Wu Z; You C; Zhu Z; Wu W; Cao J; Xie Q; Deng C; Huang X; Hu S
    Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):427-440. PubMed ID: 37688682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive characterization of the tumor microenvironment for assessing immunotherapy outcome in patients with head and neck squamous cell carcinoma.
    Zhang J; Zhong X; Jiang H; Jiang H; Xie T; Tian Y; Li R; Wang B; Zhang J; Yuan Y
    Aging (Albany NY); 2020 Nov; 12(22):22509-22526. PubMed ID: 33216727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    He F; Chen Z; Deng W; Zhan T; Huang X; Zheng Y; Yang H
    Int Immunopharmacol; 2021 Sep; 98():107789. PubMed ID: 34130150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Machine learning developed a macrophage signature for predicting prognosis, immune infiltration and immunotherapy features in head and neck squamous cell carcinoma.
    Wang Y; Mou YK; Liu WC; Wang HR; Song XY; Yang T; Ren C; Song XC
    Sci Rep; 2024 Aug; 14(1):19538. PubMed ID: 39174693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatic analysis identifies HPV-related tumor microenvironment remodeling prognostic biomarkers in head and neck squamous cell carcinoma.
    Zhou Q; Yuan O; Cui H; Hu T; Xiao GG; Wei J; Zhang H; Wu C
    Front Cell Infect Microbiol; 2022; 12():1007950. PubMed ID: 36425786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel metabolic-related gene signature for predicting clinical prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Cao Y; Dai Z; Xie G; Liu G; Guo L; Zhang J
    Exp Cell Res; 2023 Jul; 428(2):113628. PubMed ID: 37149080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.